Effect of Remimazolam on Postoperative Nausea and Vomiting
Status:
Recruiting
Trial end date:
2024-04-12
Target enrollment:
Participant gender:
Summary
The present trial is to study the effect of low dose remimazolam on postoperative nausea and
vomiting (PONV) in patients at risks of PONV (women, postoperative use of opioid, nonsmokers)
undergoing laparoscopic cholecystectomy.